It is well recognised that polymyalgia rheumatica (PMR) is often a manifestation of giant cell arteritis (GCA), and in some myalgic patients biopsy of an asymptomatic and apparently normal temporal artery may reveal the classical histological appearances of GCA.
The true relationship between PMR and GCA remains uncertain. Some1 2 consider that polymyalgia is always a manifestation of GCA. Others disagree with this view; they point out that most patients with PMR followed up for many years never develop evidence of cranial arteritis and consider it to be a benign condition. 3 Fauchald et al.1 found that 40% of patients with myalgia alone had a positive biopsy, and other studies suggest that this occurs in 6 %4 to 50%5 of patients. The cause of this variation is uncertain but may be explained in part by the selection of cases. The interpretation of temporal artery biopsies can be complicated by the presence of skin lesions, which were identified in 28% of patients with temporal arteritis. 6 The true incidence of arteritis in polymyalgia is probably higher than reported. The onset of myalgic symptoms may precede, coincide with, or follow that of the arteritic symptoms. No difference has been found between the characteristics of those myalgic patients with a positive biopsy and those with no histological evidence of arteritis. ' GCA can lead to blindness, deafness, and cerebral Accepted for publication 12 There is also a divergence of views about the length of time for which steroids should be continued. Russell7 suggested 6 months' treatment was usually sufficient, and more recently Huston et al. '2 found that it was possible to withdraw steroids within 1 year from 23 out of 43 patients with positive temporal artery biopsies. Hamilton et al.,2 however, showed that disabling vascular occlusive episodes may occur from 6 months to 2 years after initiating treatment. Fauchald Table 1 ) had negative biopsies early in the disease.
The clinical details of the 28 patients who later developed symptoms of GCA are shown ( Table 2) . Headache was the most prominent symptom. The length of time from onset of PMR to the development of GCA is shown in Fig. 1 (mean interval 1 year; range 1 month-9 years). Table 3 lists the neurological and visual complications seen in the 4 groups of patients. A serious or potentially serious complication of GCA occurred in 22 (26%) of all 85 patients and in 15 (53 %) of 28 patients in the PMR->GCA group. Exclusion of the 
